NCT01243775View on ClinicalTrials.gov

BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Belotaxel

60 mg/m2 3 weekly (day 1)

DRUG

Belloxa

70 mg/m2 3 weekly (day 2)

Trial Locations (1)

519-809

Chonnam National University Hwasun Hospital, Hwasun

Sponsors
All Listed Sponsors
collaborator

Chong Kun Dang Pharmaceutical

INDUSTRY

lead

Chonnam National University Hospital

OTHER